By Kumar Mukherjee, PhD
Pharmacoeconomics and outcomes research is a combination of two distinct fields. The discipline of pharmacoeconomics can help to measure and value the outcomes of different types of healthcare interventions with particular focus on pharmaceuticals. Outcomes research includes a set of scientific disciplines which helps to evaluate the effect of different healthcare interventions on patients.
Outcomes research creates evidence about benefits, risks, and results of treatments. According to the Patient Centered Outcomes Research Institute (PCORI), the purpose of outcomes research is to assist patients, clinicians, purchasers and policy makers in making informed health decisions by producing quality and relevant evidence.
There are three different types of outcomes research related to pharmaceuticals: economic outcomes (this is commonly known as pharmacoeconomics), clinical (comparative clinical effectiveness research) or humanistic (health-related quality of life). Pharmacoeconomics examines and compares the costs and benefits of various pharmaceutical interventions. Comparative clinical effectiveness research evaluates and compares health outcomes and clinical effectiveness, risks and benefits of two or more medical treatments, services or items. Health-related quality of life research is focused on assessing the impact that an individual’s health—including chronic illness and disabilities—may have on that person’s quality of life.
Pharmacists participate in health economics and outcomes research (HEOR) in many ways. HEOR jobs for pharmacists includes work focused on the following areas:
Pharmacy students interested in health economics and outcomes research can do advanced pharmacy practice experiences (APPE) rotations in the pharmaceutical industry or contract research organizations focusing on pharmacoeconomics and outcomes research.
After graduation, a new pharmacist can also do industry academia collaborative fellowships, which will prepare them for outcomes research jobs in the pharmaceutical industry.